Form D · Other Health Care
RST Implanted Cell Technology, Inc.
St. Paul, MN · CIK 0001524186
Offering snapshot reported Jun 27, 2011 · SEC filing
- Reported sold
- $155K Offering amount: $750K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 8, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 27, 2011 | Initial | $154,750 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-161853
Source: Form D, filed Jun 27, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Farrow | Director |
| Stanley Harpstead | Director, Executive |
| Steve Le Vahn | Director |
| Kevin Nickels | Director, Executive |
| W. Thomas Waddell | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1246 University Ave. W. #211
St. Paul, MN, 55104
St. Paul, MN, 55104